Larkin Finbar 4
4 · Jazz Pharmaceuticals plc · Filed Mar 10, 2020
Insider Transaction Report
Form 4
Larkin Finbar
SVP, Technical Development
Transactions
- Sale
Ordinary Shares
2020-03-06$119.15/sh−292$34,793→ 14,498 total - Sale
Ordinary Shares
2020-03-09$111.49/sh−615$68,566→ 13,883 total
Footnotes (2)
- [F1]Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
- [F2]Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $111.4701 to $111.5101. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.